Document Type
Article
Publication Date
11-2022
Abstract
The US health care system has encountered long-standing, complex challenges, including growing costs, overuse of care, staffing shortages and supply chain weaknesses. COVID-19 revived these pressures, transforming the health care landscape. Medication and staffing shortages plague hospital systems, and pharmacies are not exempt. Most health systems have experienced high levels of pharmacy technician turnover, with most reporting a minimum turnover rate of 21% last year. In addition, medication shortages of critical medications and infusions create significant workflow barriers that hospitals must address to ensure patient safety. In the face of these obstacles, health systems are turning to 503B compounding facilities to outsource pharmacy needs.
Recommended Citation
Clemente, Sarah; Riley, Brittany; Coustasse, Alberto. Evaluate 503B Facilities for Outsourced Compounds. Pharmacy Times Health Systems Edition. November 17, 2022 Volume 11, Issue 6 – p 24 & 26.
Included in
Business Administration, Management, and Operations Commons, Pharmacoeconomics and Pharmaceutical Economics Commons
Comments
The copy or record is available from the publisher at https://www.pharmacytimes.com/view/evaluate-503b-facilities-for-outsourced-compounds. Copyright © 2022 Pharmacy Times. Reprinted with permission. All rights reserved.